| Journal Ref. |
Eriksson S, Olofsson BO, P.O. W, group ftTs: Atenolol for secondary prevention after stroke. Cerebrovasc Dis 1995, 5:21-25. |
| Intervention |
Drug - Anti-hypertensive |
| Number of sites |
21 |
| Countries involved |
Sweden |
| Sample size |
720 |
| Type of statistical analyses |
|
| Risk of bias |
Overall: Low Risk
details
Random sequence generation:
-
Allocation concealment:
-
Blinding of participants, personal and outcome assessors:
-
Incomplete outcome data:
-
Selective outcome reporting:
-
Other sources of bias:
-
|
| Duration of trial |
|
| Primary outcome |
Death from any cause, non-fatal MI and non-fatal stroke |
